HRP20110083T1 - Uporaba agomelatina u proizvodnji lijeka za liječenje bipolarnih poremećaja - Google Patents
Uporaba agomelatina u proizvodnji lijeka za liječenje bipolarnih poremećaja Download PDFInfo
- Publication number
- HRP20110083T1 HRP20110083T1 HR20110083T HRP20110083T HRP20110083T1 HR P20110083 T1 HRP20110083 T1 HR P20110083T1 HR 20110083 T HR20110083 T HR 20110083T HR P20110083 T HRP20110083 T HR P20110083T HR P20110083 T1 HRP20110083 T1 HR P20110083T1
- Authority
- HR
- Croatia
- Prior art keywords
- treatment
- pharmaceutically acceptable
- intended
- pharmaceutical preparations
- hydrates
- Prior art date
Links
- 208000020925 Bipolar disease Diseases 0.000 title claims abstract 10
- 239000003814 drug Substances 0.000 title claims abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 claims abstract 9
- 239000002253 acid Substances 0.000 claims abstract 6
- 229960002629 agomelatine Drugs 0.000 claims abstract 6
- 150000004677 hydrates Chemical class 0.000 claims abstract 6
- 150000003839 salts Chemical class 0.000 claims abstract 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 210000001541 thymus gland Anatomy 0.000 claims 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims 1
- 229940102566 valproate Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0503937A FR2884714B1 (fr) | 2005-04-20 | 2005-04-20 | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110083T1 true HRP20110083T1 (hr) | 2011-03-31 |
Family
ID=35311309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110083T HRP20110083T1 (hr) | 2005-04-20 | 2011-02-02 | Uporaba agomelatina u proizvodnji lijeka za liječenje bipolarnih poremećaja |
Country Status (41)
| Country | Link |
|---|---|
| US (1) | US7947743B2 (zh) |
| EP (1) | EP1714647B1 (zh) |
| JP (2) | JP4580364B2 (zh) |
| KR (2) | KR100835451B1 (zh) |
| CN (2) | CN102038669A (zh) |
| AP (1) | AP2656A (zh) |
| AR (1) | AR057277A1 (zh) |
| AT (1) | ATE491443T1 (zh) |
| AU (1) | AU2006201655B2 (zh) |
| BR (1) | BRPI0601285A8 (zh) |
| CA (1) | CA2544136C (zh) |
| CR (1) | CR9426A (zh) |
| CY (1) | CY1111257T1 (zh) |
| DE (1) | DE602006018822D1 (zh) |
| DK (1) | DK1714647T3 (zh) |
| EA (1) | EA013462B1 (zh) |
| ES (1) | ES2357901T3 (zh) |
| FR (1) | FR2884714B1 (zh) |
| GE (1) | GEP20094651B (zh) |
| GT (1) | GT200600141A (zh) |
| HK (1) | HK1093906A1 (zh) |
| HR (1) | HRP20110083T1 (zh) |
| IL (1) | IL186373A (zh) |
| JO (1) | JO2666B1 (zh) |
| MA (1) | MA28266A1 (zh) |
| ME (1) | ME01951B (zh) |
| MY (1) | MY143171A (zh) |
| NO (1) | NO336010B1 (zh) |
| NZ (1) | NZ546630A (zh) |
| PE (1) | PE20061337A1 (zh) |
| PL (1) | PL1714647T3 (zh) |
| PT (1) | PT1714647E (zh) |
| RS (1) | RS51659B (zh) |
| SG (1) | SG126868A1 (zh) |
| SI (1) | SI1714647T1 (zh) |
| TN (1) | TNSN07364A1 (zh) |
| TW (2) | TW200940049A (zh) |
| UA (1) | UA83681C2 (zh) |
| UY (1) | UY29470A1 (zh) |
| WO (1) | WO2006111653A1 (zh) |
| ZA (1) | ZA200603160B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2890563B1 (fr) * | 2005-09-09 | 2007-10-19 | Servier Lab | Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent |
| US7608737B2 (en) | 2007-05-01 | 2009-10-27 | Concert Pharmaceuticasl Inc. | Naphthyl(ethyl)acetamides |
| FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| EP2856934A1 (en) * | 2013-10-04 | 2015-04-08 | Les Laboratoires Servier | Biomarkers for the prediction of long term remission in depression |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5585118A (en) * | 1995-06-02 | 1996-12-17 | Brigham And Women's Hospital | Choline in the treatment of bipolar disorder |
| US7122576B2 (en) * | 2001-02-27 | 2006-10-17 | Plata-Salaman Carlos R | Carbamate compounds for use in preventing or treating bipolar disorder |
| FR2834890B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
| AR047553A1 (es) * | 2003-07-04 | 2006-01-25 | Lundbeck & Co As H | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina |
| WO2005063297A2 (en) * | 2003-12-24 | 2005-07-14 | Sepracor Inc. | Melatonin combination therapy for improving sleep quality |
-
2005
- 2005-04-20 FR FR0503937A patent/FR2884714B1/fr not_active Expired - Fee Related
- 2005-06-01 US US11/142,612 patent/US7947743B2/en not_active Expired - Fee Related
-
2006
- 2006-04-04 PE PE2006000362A patent/PE20061337A1/es not_active Application Discontinuation
- 2006-04-04 JO JO200690A patent/JO2666B1/en active
- 2006-04-07 UY UY29470A patent/UY29470A1/es not_active Application Discontinuation
- 2006-04-07 GT GT200600141A patent/GT200600141A/es unknown
- 2006-04-11 SG SG200602393A patent/SG126868A1/en unknown
- 2006-04-11 UA UAA200604022A patent/UA83681C2/uk unknown
- 2006-04-17 MA MA28940A patent/MA28266A1/fr unknown
- 2006-04-18 NO NO20061705A patent/NO336010B1/no not_active IP Right Cessation
- 2006-04-19 TW TW098118938A patent/TW200940049A/zh unknown
- 2006-04-19 GE GEAP20069356A patent/GEP20094651B/en unknown
- 2006-04-19 AR ARP060101537A patent/AR057277A1/es not_active Application Discontinuation
- 2006-04-19 EA EA200600600A patent/EA013462B1/ru not_active IP Right Cessation
- 2006-04-19 TW TW095113952A patent/TWI318115B/zh not_active IP Right Cessation
- 2006-04-19 DK DK06290636.7T patent/DK1714647T3/da active
- 2006-04-19 AT AT06290636T patent/ATE491443T1/de active
- 2006-04-19 AP AP2007004212A patent/AP2656A/xx active
- 2006-04-19 PL PL06290636T patent/PL1714647T3/pl unknown
- 2006-04-19 RS RS20110110A patent/RS51659B/en unknown
- 2006-04-19 PT PT06290636T patent/PT1714647E/pt unknown
- 2006-04-19 SI SI200630921T patent/SI1714647T1/sl unknown
- 2006-04-19 DE DE602006018822T patent/DE602006018822D1/de active Active
- 2006-04-19 EP EP06290636A patent/EP1714647B1/fr active Active
- 2006-04-19 KR KR1020060035392A patent/KR100835451B1/ko not_active IP Right Cessation
- 2006-04-19 ES ES06290636T patent/ES2357901T3/es active Active
- 2006-04-19 WO PCT/FR2006/000859 patent/WO2006111653A1/fr active Application Filing
- 2006-04-19 NZ NZ546630A patent/NZ546630A/en not_active IP Right Cessation
- 2006-04-19 ME MEP-2011-231A patent/ME01951B/me unknown
- 2006-04-19 MY MYPI20061783A patent/MY143171A/en unknown
- 2006-04-20 JP JP2006116294A patent/JP4580364B2/ja not_active Expired - Fee Related
- 2006-04-20 CA CA2544136A patent/CA2544136C/fr not_active Expired - Fee Related
- 2006-04-20 CN CN2010105781057A patent/CN102038669A/zh active Pending
- 2006-04-20 CN CN2006100764985A patent/CN1853619B/zh not_active Expired - Fee Related
- 2006-04-20 AU AU2006201655A patent/AU2006201655B2/en not_active Ceased
- 2006-04-20 ZA ZA200603160A patent/ZA200603160B/en unknown
- 2006-04-20 BR BRPI0601285A patent/BRPI0601285A8/pt not_active IP Right Cessation
-
2007
- 2007-01-10 HK HK07100339.3A patent/HK1093906A1/xx not_active IP Right Cessation
- 2007-09-26 TN TNP2007000364A patent/TNSN07364A1/en unknown
- 2007-10-07 IL IL186373A patent/IL186373A/en not_active IP Right Cessation
- 2007-10-08 CR CR9426A patent/CR9426A/es not_active Application Discontinuation
-
2008
- 2008-02-29 KR KR1020080018845A patent/KR20080028389A/ko not_active Application Discontinuation
-
2010
- 2010-08-06 JP JP2010177003A patent/JP5341037B2/ja not_active Expired - Fee Related
-
2011
- 2011-02-02 HR HR20110083T patent/HRP20110083T1/hr unknown
- 2011-02-23 CY CY20111100222T patent/CY1111257T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR056063A1 (es) | Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento de trastornos del sueno en el paciente deprimido | |
| HRP20100577T1 (hr) | Uporaba agomelatina za dobivanje lijeka s ciljem liječenja općeg poremećaja anksioznosti | |
| MX2019013574A (es) | Amidas de piridona deuteradas y sus profarmacos como moduladores de los canales de sodio. | |
| BRPI1006812A8 (pt) | sal de malato de n-(4-{[6,7-bis(metiloxi)quinolin-4-il]fenil)-n-(4-fluorofenil)ciclopropane-1,1-dicarboxamida | |
| GEP20043160B (en) | Biaryl Ether Derivatives, Pharmaceutical Compositions Containing Them and Their Use as Monoamine Reuptake Inhibitors | |
| HRP20110083T1 (hr) | Uporaba agomelatina u proizvodnji lijeka za liječenje bipolarnih poremećaja | |
| BR112014009851A2 (pt) | moduladores de receptor de nmda e usos dos mesmos | |
| DE60027463D1 (de) | Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon | |
| RS51961B (en) | APPLICATION OF FLIBANSERINE FOR TREATMENT OF SEXUAL DESIRE DISORDERS IN PREMENOPAUSE | |
| RU2015115064A (ru) | Композиции для непрерывного введения ингибиторов допа-декарбоксилазы | |
| HK1117824A1 (en) | Acyloxyalkyl carbamate prodrugs of tranexamic acid and use | |
| UY27619A1 (es) | Ésteres hidroxamato del ácido n-(4-fenil sustituido)- antranílico | |
| NZ593994A (en) | Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators | |
| BR112015025804A2 (pt) | derivados de glutarimida, uso dos mesmos, composição farmacêutica com base neles e métodos para a produção de derivados de glutarimida | |
| RU2007137115A (ru) | Новые офтальмологические композиции и способы их применения | |
| HUP0401694A2 (hu) | Egy hidroxinorefedrin-származék hidrokloridjának kristályalakjai, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| CL2009000980A1 (es) | Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006). | |
| HRP20110370T1 (hr) | Uporaba agomelatina za dobivanje lijeka u cilju liječenja smith-magenisovog sindroma | |
| MX2023012521A (es) | Formas en estado solido de (s)-n-(3-(2-((r)-1-hidroxipropano-2-il) amino)-6-morfolinopiridin-4-il)-4-metilfenil)-3-(2,2,2-trifluoroe til)pirrolidin-1-carboxamida y sales de las mismas. | |
| HRP20120344T1 (hr) | N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije | |
| RU2013129917A (ru) | Новое соединение и его применение в медицине | |
| AR073848A1 (es) | Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica. | |
| RS50693B (sr) | Stabilni farmaceutski gel diklofenak natrijuma | |
| RU2013114246A (ru) | Комбинация hdac ингибиторов с лекарственными средствами против тромбоцитопении | |
| TW200507853A (en) | Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |